Definitions
from Wiktionary, Creative Commons Attribution/Share-Alike License.
- noun A
glucagon -likepeptide -1agonist drug under investigation for treatment ofdiabetes .
Etymologies
Sorry, no etymologies found.
Support
Help support Wordnik (and make this page ad-free) by adopting the word albiglutide.
Examples
-
Another drug, albiglutide, is also undergoing testing in a large clinical trial.
Glaxo Looks for Gene-Research Payoff on Other Drugs Jeanne Whalen 2011
-
There are already two similar drugs on the market, so albiglutide would have to demonstrate significantly better efficacy or safety if it is to gain market share.
Glaxo Looks for Gene-Research Payoff on Other Drugs Jeanne Whalen 2011
-
In addition, HGS has substantial financial rights to certain products in the GSK clinical pipeline including darapladib, in Phase 3 development in patients with coronary heart disease, and Syncria® (albiglutide), in Phase 3 development in patients with type 2 diabetes.
-
Novel diabetes treatment Syncria (albiglutide) improves glucose control and reduces weight
THE MEDICAL NEWS 2009
-
Novel diabetes treatment Syncria (albiglutide) improves glucose control and reduces weight
THE MEDICAL NEWS 2009
-
In addition, HGS has substantial financial rights to certain products in the GSK clinical pipeline including darapladib, currently in Phase 3 development as a potential treatment for coronary heart disease, and Syncria® (albiglutide), currently in Phase 3 development as a potential treatment for type 2 diabetes.
-
In addition, HGS has substantial financial rights to certain products in the GSK clinical pipeline including darapladib, currently in Phase 3 development as a potential treatment for coronary heart disease, and Syncria® (albiglutide), currently in Phase 3 development as a potential treatment for type 2 diabetes.
-
In addition, HGS has substantial financial rights to certain products in the GSK clinical pipeline including darapladib, currently in Phase 3 development in patients with coronary heart disease, and Syncria (r) (albiglutide), currently in Phase 3 development in patients with type 2 diabetes.
News 2009
-
In addition, HGS has substantial financial rights to certain products in the GSK clinical pipeline including darapladib, currently in Phase 3 development in patients with coronary heart disease, and Syncria (R) (albiglutide), currently in Phase 3 development in patients with type 2 diabetes.
Gaea Times (by Simple Thoughts) Breaking News and incisive views 24/7 2009
-
In addition, HGS has substantial financial rights to certain products in the GSK clinical pipeline including darapladib, currently in Phase 3 development in patients with coronary heart disease, and Syncria® (albiglutide), currently in Phase 3 development in patients with type 2 diabetes.
unknown title 2009
Comments
Log in or sign up to get involved in the conversation. It's quick and easy.